Ieq Capital LLC acquired a new position in Xeris Pharmaceuticals, Inc. (NASDAQ:XERS – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 50,169 shares of the company’s stock, valued at approximately $147,000. Ieq Capital LLC owned about 0.08% of Xeris Pharmaceuticals as […]
Equities research analysts expect Xeris Pharmaceuticals, Inc. (NASDAQ:XERS – Get Rating) to report sales of $22.97 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimates for Xeris Pharmaceuticals’ earnings. The highest sales estimate is $24.10 million and the lowest is $22.28 million. Xeris Pharmaceuticals posted sales of $8.05 […]
Wall Street brokerages expect Xeris Pharmaceuticals, Inc. (NASDAQ:XERS – Get Rating) to report sales of $22.97 million for the current quarter, according to Zacks. Four analysts have made estimates for Xeris Pharmaceuticals’ earnings. The highest sales estimate is $24.10 million and the lowest is $22.28 million. Xeris Pharmaceuticals posted sales of $8.05 million during the […]